Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ischemic stroke in an obese patient receiving dabigatran.

× No keyword cloud information.

12 in total

1. Pulmonary embolism in a morbidly obese patient receiving dabigatran.

Authors: Usama Nasir
Journal: Clin Cardiol Date: 2017-07-10 Impact factor: 2.882

2. Coagulation assays and plasma fibrinogen concentrations in real-world patients with atrial fibrillation treated with dabigatran.

Authors: Paul K L Chin; David M Patterson; Mei Zhang; Berit P Jensen; Daniel F B Wright; Murray L Barclay; Evan J Begg
Journal: Br J Clin Pharmacol Date: 2014-09 Impact factor: 4.335

3. Preventability of serious thromboembolic and bleeding events related to the use of oral anticoagulants: a prospective study.

Authors: Anne-Laure Sennesael; Anne-Sophie Larock; Bérangère Devalet; Valérie Mathieux; Franck Verschuren; Xavier Muschart; Olivia Dalleur; Jean-Michel Dogné; Anne Spinewine
Journal: Br J Clin Pharmacol Date: 2018-04-17 Impact factor: 4.335

Review 4. Initial anticoagulation in patients with pulmonary embolism: thrombolysis, unfractionated heparin, LMWH, fondaparinux, or DOACs?

Authors: Jenneke Leentjens; Mike Peters; Anne C Esselink; Yvo Smulders; Cornelis Kramers
Journal: Br J Clin Pharmacol Date: 2017-07-09 Impact factor: 4.335

5. Rivaroxaban Pharmacokinetics in Obese Subjects: A Systematic Review.

Authors: Majdoleen Alalawneh; Ahmed Awaisu; Ousama Rachid
Journal: Clin Pharmacokinet Date: 2022-10-06 Impact factor: 5.577

Review 6. Management of rivaroxaban in relation to bodyweight and body mass index.

Authors: James Uprichard
Journal: Ther Adv Cardiovasc Dis Date: 2016-04-17

Review 7. The case for dosing dabigatran: how tailoring dose to patient renal function, weight and age could improve the benefit-risk ratio.

Authors: Apostolos Safouris; Nikos Triantafyllou; John Parissis; Georgios Tsivgoulis
Journal: Ther Adv Neurol Disord Date: 2015-11 Impact factor: 6.570

8. Body Mass Index Influence on the Clinical Outcomes for Nonvalvular Atrial Fibrillation Patients Admitted to a Hospital Treated with Direct Oral Anticoagulants: A Retrospective Cohort Study.

Authors: Xiaoye Li; Chengchun Zuo; Qiuyi Ji; Ying Xue; Zi Wang; Qianzhou Lv
Journal: Drug Des Devel Ther Date: 2021-05-06 Impact factor: 4.162

Review 9. A review of the fixed dose use of new oral anticoagulants in obese patients: Is it really enough?

Authors: Ekrem Güler; Gamze Babur Güler; Gültekin Günhan Demir; Suzan Hatipoğlu
Journal: Anatol J Cardiol Date: 2015 Impact factor: 1.596

10. Clinical pharmacist led hospital-wide direct oral anticoagulant stewardship program.

Authors: Amichai Perlman; Ehud Horwitz; Bruria Hirsh-Raccah; Gefen Aldouby-Bier; Tamar Fisher Negev; Sarit Hochberg-Klein; Yosef Kalish; Mordechai Muszkat
Journal: Isr J Health Policy Res Date: 2019-02-01